Clinical Trials Logo

Clinical Trial Summary

The randomized, controlled clinical trial investigate the efficacy and safety of vildagliptin added to continuous subcutaneous insulin infusion in uncontrolled type 2 diabetes


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03563794
Study type Interventional
Source The First Affiliated Hospital of Xiamen University
Contact Xiulin Shi, MD
Phone 13959284763
Email shixiulin2002@163.com
Status Recruiting
Phase Phase 4
Start date June 10, 2018
Completion date December 10, 2019

See also
  Status Clinical Trial Phase
Not yet recruiting NCT04544319 - Clinical Trial to Compare the PK of the Fixed-dose Combinations and Each Component of Gemigliptin/Dapagliflozin 50/10 mg Phase 1
Recruiting NCT05996380 - A Phase 1 Trial to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SHR-3167 Single Injection in Healthy Subjects and Patients With Type 2 Diabetes Phase 1
Recruiting NCT02037100 - Sleep Disordered Breathing and Impaired Glucose Homeostasis in Obese Children N/A
Completed NCT01990469 - Efficacy and Safety of Gemigliptin 50mg qd Added in Patients With Type 2 Diabetes Inadequately Controlled on Glimepiride and Metformin Phase 3
Active, not recruiting NCT05680129 - A Phase 3 Study to Evaluate the Efficacy of XW003 Compared With Dulaglutide in Participants With T2DM Phase 3
Active, not recruiting NCT04609631 - Tai Chi for Comorbid Depression in T2DM Patients N/A
Completed NCT05681273 - Drug-Drug Interaction Study of Chiglitazar in Healthy Subjects. Phase 1
Active, not recruiting NCT05680155 - A Phase 3 Study to Evaluate the Efficacy of XW003 Compared With Placebo in T2DM Patients Phase 3
Recruiting NCT03564431 - The Imaging Genetic Study of Type 2 Diabetes and Depression
Recruiting NCT05159882 - Safety and Efficacy of THR-1442 Compared to Dapagliflozin as Add-on Therapy to Metformin in T2DM Phase 3